Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials

<table>Funnel plot for publication bias test PFS. The two oblique lines indicate the pseudo 95% confidence limits.</table>

Gastroenterology Research and Practice

fig7

Figure 7

Figure 7: Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials 

Figure 7 | Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials 